Like Omhu A/S

closed 2/16/2022 via BusinessWire

Medable, acquired Omhu A/S

synopsis: Medable Inc., the leading software provider for patient-centered clinical trials, announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
buyer: Medable
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials. "
target parent: LEO Pharma Inc.
target: Omhu A/S
Omhu is a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. Omhu’s software applications include Imagine, a skin-tracking mobile app, and Omhu Care, a telemedicine app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2018 via BNC Analysis

Netmeds Marketplace Limited, acquired JustDoc

synopsis: Chennai-based online pharmacy NetMeds Marketplace Pvt. Ltd has acquired online video consultation app JustDoc. NetMeds will fully absorb the JustDoc team, integrate its technology with Netmeds.com. JustDoc, run by Bangalore-based Godel Technologies Pvt Ltd, was founded in August 2015 by IIT graduates Jugal Anchalia, Abhishek Kumar and Vikash Singh.
buyer: Netmeds Marketplace Limited
NetMeds lets users order their medicines via its portal and mobile app by uploading their prescriptions. A team of qualified pharmacists verifies the prescription for validity and prescribes the appropriate dosage accordingly. NetMeds is based in Chennai, India. "
target: JustDoc
Bangalore-based JustDoc enables patients to do video consultations with doctors via its website and app. JustDoc, run by Bangalore-based Godel Technologies Pvt Ltd, was founded in August 2015 by IIT graduates Jugal Anchalia, Abhishek Kumar and Vikash Singh.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/10/2022 via BNC Analysis

Infohealth Ltd, acquired Quin

synopsis: Infohealth Ltd, a leading UK pharmacy-led developer of hyper-personalised digital health solutions, has acquired Quin Technology, a diabetes management app in the UK. Quin helps people to manage their Type 1 diabetes. The AI-powered app allows users to record and plan their food, insulin and activity, and provides them with personalized insights.
buyer: Infohealth Ltd
Infohealth is a leading UK pharmacy-led developer of hyper-personalised digital health solutions. Infohealth's business operations include pharmacies, a telehealth mobile app, pharmaceutical manufacturing, and medicines management services for care homes. "
target: Quin
Quin is a diabetes management app in the UK. Quin helps people to manage their Type 1 diabetes. The app allows users to record and plan food, insulin and activity to see how each affects their blood sugar. Their app uses AI to provide personalized insights based on the user's data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2022 via GlobeNewswire

ResMed, acquired mementor DE GmbH

synopsis: ResMed announced the acquisition of Leipzig-based company mementor. mementor developed and owns the digital insomnia therapy solution somnio, which is Germany’s first and only permanently approved Digital Health Application (DiGA) in the field of sleep medicine and thus eligible for reimbursement in Germany.
buyer: ResMed (RMD:$3,443.76)
ResMed, a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. "
target: mementor DE GmbH
Founded in 2014 and based in Leipzig, Germany, mementor developed and owns the digital insomnia therapy solution somnio, which is Germany’s first and only permanently approved Digital Health Application (DiGA) in the field of sleep medicine and thus eligible for reimbursement in Germany.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/23/2022 via BusinessWire

Afya Participações S.A., acquired Glic

synopsis: Afya Limited announced the acquisition, through its wholly-owned subsidiary Afya Participações S.A, of 100% of Glic. Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and health providers.
buyer parent: Afya Limited
buyer: Afya Participações S.A.
Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners. "
target: Glic
Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and health providers.
price ($mm)
$4.52
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/16/2022 via BNC Analysis

Glooko, acquired Diabnext

synopsis: Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, has acquired Diabnext, a diabetes management app in France. Diabnext enables people with diabetes to better manage their health by automatically collecting data into a digital logbook.
buyer: Glooko
Glooko is a provider of remote patient monitoring and digital health solutions. Glooko is transforming digital health by connecting people with diabetes and other chronic conditions with their healthcare teams, enabling collaborative telehealth, clinical research and improved health outcomes. "
target: Diabnext
Diabnext is a diabetes management app in France. Diabnext helps people with diabetes to better manage their health and stay connected with their healthcare providers. The app enables users to better manage their diabetes by automatically collecting data into a digital logbook.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/16/2020 via BNC Analysis

Fuming Yang, acquired Kelinda

synopsis: Fuming Yang, a Chinese entrepreneur, has acquired a 99% stake in Kelinda, a healthcare focused software company in Moldova. Kelinda offers a mobile app that features various health control panels and reminders. The app allows users to more easily monitor the condition of their health with reminders and notifications for medication and appointments.
buyer: Fuming Yang
Fuming Yang is a Chinese entrepreneur. Fuming Yang is the founder of Liuzhou Bangfu Technology Co., Ltd., a company focusing on internet technology development, maintenance and services. Mr. Yang was also involved in various media projects, such as Star Avenue on CCTV. "
target: Kelinda
Kelinda is a healthcare focused software company in Moldova. Kelinda offers a mobile app that features various health control panels and reminders. The app allows users to more easily monitor the condition of their health with reminders and notifications for medication and doctor appointments.
price ($mm)
$0.33*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2018 via Company Press Release

Varian Medical Systems, Inc., acquired Noona Healthcare

synopsis: Varian, a leader in developing and delivering cancer care solutions, has announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs).
buyer: Varian Medical Systems, Inc. (VAR:$2,888.20)
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Varian has pioneered developments in radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. "
target: Noona Healthcare
Noona Healthcare is the developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). The Noona patient software app lets clinics capture PROs and communicate directly with patients. They are based in Finland.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/11/2017 via BNC Analysis

StayWell, acquired MedHelp

synopsis: StayWell, a health engagement company, has acquired MedHelp, the largest online health community and consumer health platform. MedHelp empowers 19 million users a month to better understand and better manage their health. They also provide mobile apps such as My Diet Diary, a calorie tracking app, and Sugar Sense, a top-ranked diabetes app.
buyer parent: Merck & Co., Inc.
buyer: StayWell
StayWell is a health engagement company that helps its clients engage and educate people to improve health and business results. StayWell brings decades of experience working across the health care industry to design solutions that address its clients’ evolving needs. "
target: MedHelp
MedHelp is the largest online health community and consumer health platform, empowering 19 million unique users a month to better understand and better manage their health. MedHelp also provides mobile apps such as My Diet Diary, a calorie tracking app, and Sugar Sense, a top-ranked diabetes app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/16/2017 via BNC Analysis

Verily Life Sciences, acquired Senosis Health Inc.

synopsis: Google's Verily unit has acquired Senosis Health. Senosis has developed a family of medical condition monitoring and measurement applications for use via smartphones.
buyer parent: Google Inc.
buyer: Verily Life Sciences
Verily lives at the intersection of technology, data science and healthcare. Verily is developing tools to collect and organize health data, then creating interventions and platforms that put insights derived from that health data to use for more holistic care management. "
target: Senosis Health Inc.
Senosis Health has developed a family of smartphone apps that monitor newborn jaundice, lung function and blood hemoglobin by using the smartphone’s camera and microphone.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/30/2017 via Company Press Release

Roche Ltd, acquired mySugr GmbH

synopsis: Roche and mySugr announced that the two partners have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market.
buyer: Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target: mySugr GmbH
mySugr specializes in all-around care for people with diabetes. Its apps and services combine diabetes coaching, therapy management, unlimited test-strips, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2014 via PR Newswire

Physicians Interactive, acquired MedHelp

synopsis: Physicians Interactive, a leading provider of online and mobile clinical resources and solutions for healthcare professionals, announced the acquisition of MedHelp, the online health community and health application site.
buyer parent: Merck & Co., Inc.
buyer: Physicians Interactive
Physicians Interactive is a provider of online and mobile clinical resources and solutions for healthcare professionals. PI uses the power of networks of healthcare professionals and life sciences companies together in ways that will change the practice and business of medicine for the better. "
target: MedHelp
MedHelp is the world's largest online health community and consumer health platform, empowering 14 million unique users a month to better understand and better manage their health.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/2/2021 via BNC Analysis

IRL App, acquired AeBeZe Labs, Inc.

synopsis: IRL, the SoftBank-backed social app, is announcing its acquisition of the “digital nutrition” company AeBeZe Labs and its portfolio of IP, with the goal of making IRL a healthier and more ethically designed social networking app. AeBeZe is dedicated to pioneering programs, tools, and resources, designed to improve behavioral health.
buyer: IRL App
Used primarily by younger people under the age of 25 who aren’t active on Facebook, IRL combines social calendaring, group messaging and events. While the company had originally focused on helping users discover real-world events, it shifted its focus to virtual events amid the pandemic. "
target: AeBeZe Labs, Inc.
AeBeZe is dedicated to pioneering programs, tools, and resources, designed to improve behavioral health and boost emotional resilience. Using a portfolio of tools backed by clinical research, AeBeZe's mission is to establish a new basic standard of Digital Nutrition™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2020 via BNC Analysis

PlanetVA Pty Ltd, acquired VanKeel Solutions

synopsis: PlanetVA, a provider of virtual try-on (VTO) solutions for eyewear, announces the acquisition of VanKeel Solutions, a company that provides live 3D VTO eyewear solutions to independent retailers and eyewear companies. VanKeel Solutions’ proprietary solution, VTOLive, allows for a client-centric approach of the eyewear selection process
buyer: PlanetVA Pty Ltd
PlanetVA (VA an acronym for Visual Acuity) is a privately held independent company formed in August 1999 and incorporated in Australia and Europe. Since its inception, it has been taking on a leadership role as a pioneer in employing computer and IT technologies for the eyecare industry. "
target: VanKeel Solutions
VanKeel Solutions is a company that provides live 3D VTO (virtual try-on) eyewear solutions to independent retailers and eyewear companies. VanKeel Solutions’ proprietary solution, VTOLive, allows for a more efficient and patient or client-centric approach of the eyewear selection process
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2017 via PR Web

First Opinion, acquired Proxi

synopsis: First Opinion, Inc. announced it has acquired Incente, LLC, a behavioral health technology company based in Hanover, NH. In addition to the acquisition, First Opinion also announced the formation of a new business unit called Voi (http://voi.com).
buyer: First Opinion
First Opinion is a health technology company that offers tools for individuals and organizations. First Opinion App is an AI-assisted messenger that provides individuals access to care providers. Voi addresses vital behavioral health needs through advanced analytics and assessments. "
target: Proxi
Proxi, by Incente, is an app that provides easy access to and completion of behavioral health assessments. it enables online collaboration and connection between someone suffering with a behavioral health disorder and his/her family, friends, behavioral health coaches and clinicians.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/27/2021 via BNC Analysis

Mind Ease Labs Ltd, acquired UpLift Health Inc.

synopsis: A mental health company, Mind Ease Labs LTD., is acquiring UpLift Health Inc. the company behind a depression-reduction app, UpLift. UpLift is a comprehensive app for depression based on cognitive behavioral therapy. On average, users who complete the program see a 50% mood increase in just 1 month.
buyer: Mind Ease Labs Ltd
Founded in December 2019 Mind Ease Labs LTD. is a London-based mental health company with team members in the US, Europe and Australia. Mind Ease: Anxiety Relief app is available for iOS, Android and web. "
target: UpLift Health Inc.
UpLift Health Inc. is the company behind a depression-reduction app, UpLift. UpLift is a comprehensive app for depression based on cognitive behavioral therapy. On average, users who complete the program see a 50% mood increase in just 1 month.
price ($mm)
$10
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/24/2021 via BNC Analysis

ICAS World Ltd, acquired Hello Tomo Ltd

synopsis: ICAS World Ltd (ICAS), a leading global provider of mental health and employee wellness services, has acquired the NHS-commissioned mental health tech startup, Hello Tomo. Hello Tomo founded in 2016 to help users build and maintain healthy habits to manage depression, anxiety, and overall mental health.
buyer: ICAS World Ltd
ICAS World Ltd (ICAS) is a leading global provider of mental health and employee wellness services. ICAS International partners with organisations throughout the world to enhance performance and wellbeing, whilst reducing the costs associated with absenteeism and presenteeism. "
target: Hello Tomo Ltd
Hello Tomo founded in 2016 to help users build and maintain healthy habits to manage depression, anxiety, and overall mental health. The app encourages users to create an anonymous peer support community through photo sharing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/14/2022 via PR Newswire

PrepMD RMS, LLC, acquired LindaCare

synopsis: PrepMD RMS, the premier cardiac clinical solutions company, has acquired LindaCare, a digital health company specializing in remote monitoring. The acquired IP enables PrepMD RMS to continue to provide the broadest service and technology-based solutions and bolster its leadership position in the remote monitoring space.
buyer: PrepMD RMS, LLC
PrepMD RMS is the premier cardiac clinical solutions company, combining expert human capital and technological innovation to address complex challenges faced by cardiology offices and major healthcare systems. "
target: LindaCare
LindaCare is a digital health company specializing in integrated remote cardiac monitoring software and services. The company offers SaaS and Monitoring-as-a-Service (Maas) alternatives to meet the needs of health systems, hospitals and private practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2016 via GlobeNewswire

BioTelemetry, acquired Telcare

synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer: BioTelemetry (BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
target: Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2016 via BusinessWire

merged with Glooko,

synopsis: In a move that will accelerate the mission to make diabetes management easier worldwide, Glooko and Diasend announced they have merged into a unified company. Glooko and Diasend are well-known for making diabetes management easier by offering diabetes management and analytics platforms that facilitate data driven care for patients and clinicians.
buyer: Glooko
Glooko is the leading remote patient monitoring platform for diabetes and is trusted by the world’s leaders in diabetes care. Glooko's mobile app enables patients to easily track and proactively manage all aspects of their diabetes care. "
target:
Diasend simplifies life for people with diabetes and facilitates the work of their health care providers by optimizing diabetes data management. The company transmits, stores, and analyzes data from more than 140 glucose meters, insulin pumps, CGM systems and leading activity trackers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/16/2022 via BusinessWire

Medable, acquired Omhu A/S

synopsis: Medable Inc., the leading software provider for patient-centered clinical trials, announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
buyer: Medable
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials. "
target parent: LEO Pharma Inc.
target: Omhu A/S
Omhu is a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. Omhu’s software applications include Imagine, a skin-tracking mobile app, and Omhu Care, a telemedicine app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/16/2022 via BusinessWire

Medable, acquired Omhu A/S

synopsis: Medable Inc., the leading software provider for patient-centered clinical trials, announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
buyer: Medable
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials. "
target parent: LEO Pharma Inc.
target: Omhu A/S
Omhu is a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. Omhu’s software applications include Imagine, a skin-tracking mobile app, and Omhu Care, a telemedicine app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/26/2022 via BusinessWire

QHP Capital, L.P., acquired AutoCruitment

synopsis: QHP Capital, L.P., a leading investor in technology and healthcare companies, has acquired AutoCruitment, LLC, a leader in digital patient recruitment. AutoCruitment provides a web-based technology platform that helps pharma companies, biotechs and clinical research organizations to identify and recruit patients to participate in clinical research.
buyer parent: NovaQuest
buyer: QHP Capital, L.P.
QHP Capital is a leading investor in technology and services companies in the life sciences and healthcare sectors. QHP Capital focuses on providing capital and partnering with management teams to build leading healthcare companies in the middle market. "
target: AutoCruitment
AutoCruitment is a leader in digital patient recruitment. AutoCruitment provides a direct-to-patient, web-based technology platform that helps pharma companies, biotechs, and clinical research organizations (CROs) to identify, screen and recruit patients to participate in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/10/2022 via Company Press Release

BRANY Inc., acquired Tech Software

synopsis: BRANY announced its acquisition of Tech Software, a leading provider of SaaS compliance solutions in the higher education, academic medical center (AMC), hospital, commercial IRB, and government agency sectors. BRANY will acquire Tech Software’s comprehensive compliance solutions.
buyer: BRANY Inc.
BRANY is a national organization providing a continuum of compliance support services to investigators, hospitals, universities, academic medical centers., biotech, pharmaceutical and medical device companies. BRANY Research Services provide outsourced clinical trial start-up support services. "
target: Tech Software
Tech Software is a leading provider of software solutions in support of the research enterprise. Their award winning OneAegis (f/k/a IRBManager) research compliance SaaS solution delivers a comprehensive set of tools for IRB, IACUC, IBC, Export Control and similar compliance oversight groups.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/15/2021 via PR Newswire

Veeva Systems, acquired Veracity Logic

synopsis: Veeva Systems, the global leader in cloud software for the life sciences industry, has acquired Veracity Logic, a provider of cloud software for randomization and trial supply management (RTSM). Veracity Logic provides a robust, reliable, and user-friendly RTSM solution designed to simplify complex processes and expedite clinical trials.
buyer: Veeva Systems (VEEV:$1,762.04)
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 775 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. "
target: Veracity Logic
Veracity Logic is a provider of cloud software for randomization and trial supply management (RTSM). Veracity Logic's RTSM solution simplifies complex processes and expedites clinical trials. Their software covers a range of trial designs in pharma/biotech, medical device, and diagnostics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$34.31)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,234.90)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$41,399.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2015 via PR Web

Aris Global LLC, acquired Medsight Solutions Inc.

synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer: Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
target: Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2014 via PR Newswire

PAREXEL International Corporation, acquired ClinIntel Ltd.

synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target: ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via PR Newswire

The WIRB-Copernicus Group, acquired ePharmaSolutions, Inc.

synopsis: WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. ePharmaSolutions is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review. "
target: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Omhu A/S


read more

Omhu A/S

JustDoc

Quin

mementor DE GmbH

Glic

Diabnext

Kelinda

Noona Healthcare

MedHelp

Senosis Health Inc.

mySugr GmbH

MedHelp

AeBeZe Labs, Inc.

VanKeel Solutions

Proxi

UpLift Health Inc.

Hello Tomo Ltd

LindaCare

Telcare

read more

Omhu A/S

read more

Omhu A/S

read more

AutoCruitment

Tech Software

Veracity Logic

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

GoBalto

Sylogent

Parallel 6

SecureConsent

Clinverse, Inc.

Medsight Solutions Inc.

ClinIntel Ltd.

ePharmaSolutions, Inc.

Geography
Matching Companies
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: CNSX:NARA
 
 
 
 
 
 
 
 
PanGenomic Health Inc.
PanGenomic Health Inc.
PanGenomic is a digital health platform in Canada. PanGenomic provides people with personal control over their mental health treatments. Their Nara solution is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness.
year
2021
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.26)
Net Income ($mm)
Employees
5
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2021
rev ($mm)
$26.91
EBITDA ($mm)
($10.89)
EBIT ($mm)
($11.69)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: HLSE:HEALTH
 
 
 
 
 
 
 
 
Nightingale Health Plc
Nightingale Health Plc
Nightingale Health is a Finnish health technology company. Nightingale's mission is to bring disease prevention and a healthier life within everyone's reach. They offer a mobile blood testing platform that allows users to easily understand their current health and improve their wellbeing.
year
2020
rev ($mm)
$2.65
EBITDA ($mm)
($4.36)
EBIT ($mm)
($4.51)
Net Income ($mm)
Employees
77
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
39
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:LFER
 
 
 
 
 
 
 
 
Life on Earth, Inc.
Life on Earth, Inc.
Life on Earth is a cloud enterprise software developer. Life on Earth's mission is to rapidly grow their cloud based software and technology solutions to enable secure, smart, compliant and maintainable enterprise business solutions. The company focuses on fast emerging technologies.
year
2021
rev ($mm)
$0.03
EBITDA ($mm)
($0.64)
EBIT ($mm)
($0.96)
Net Income ($mm)
Employees
9
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ASX:RAP
 
 
 
 
 
 
 
 
ResApp Health
ResApp Health
ResApp Health is a mobile telehealth solution based in Australia. ResApp Health assists doctors and empowers patients to diagnose and manage respiratory disease. Their solution allows doctors to instantly diagnose respiratory diseases from the sound of their patient’s cough or breathing.
year
2021
rev ($mm)
$0.05
EBITDA ($mm)
($4.93)
EBIT ($mm)
($5.04)
Net Income ($mm)
Employees
510
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,158.07
EBITDA ($mm)
$194.47
EBIT ($mm)
$120.69
Net Income ($mm)
$74.78
Employees
8079
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2022
rev ($mm)
$339.59
EBITDA ($mm)
($27.37)
EBIT ($mm)
($76.52)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2021
rev ($mm)
$221.66
EBITDA ($mm)
$54.10
EBIT ($mm)
$47.15
Net Income ($mm)
$38.31
Employees
1515
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Cambridge Cognition
Cambridge Cognition is a global technology company developing digital health products for better brain health. Cambridge Cognition's software products assess cognitive health in patients to improve clinical trial outcomes and improve global efficiency in the pharmaceutical and healthcare industries.
year
2022
rev ($mm)
$11.47
EBITDA ($mm)
$0.29
EBIT ($mm)
$0.19
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2022
rev ($mm)
$339.59
EBITDA ($mm)
($27.37)
EBIT ($mm)
($76.52)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2021
rev ($mm)
$26.91
EBITDA ($mm)
($10.89)
EBIT ($mm)
($11.69)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.90
EBITDA ($mm)
$6.31
EBIT ($mm)
$5.20
Net Income ($mm)
$3.13
Employees
304
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
39
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch